VarmX
PrivateLast Round
M&A
Sep 16, 2024
Total Funding Raised
$87.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VarmX is a biotechnology company that develops therapeutic drugs designed to restore blood clotting in bleeding patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VarmX Comparables
Compare VarmX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alveron Pharma | 82% | |
| Azurity Pharmaceuticals | 82% | |
| AstraZeneca | 81% |
VarmX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Sep 16, 2024 | ||||
| Series B Extension | May 25, 2023 | ||||
| Grant | Oct 21, 2021 | ||||
| Series B | Jul 8, 2020 | ||||
| Debt | Jul 2, 2018 | ||||
Series A | Jul 2, 2018 |
Key People
Founding team and executive leadership
VarmX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series B |
| European Innovation Council Fund | Grant, Series B Extension |
| EQT Life Sciences | Series B Extension |
| Lundbeckfonden BioCapital | Series B Extension |
| Ysios Capital | Series B Extension, Series B |
| BioGeneration Ventures | Series B Extension, Series B, Seed, Series A |
| Bgvcat | Series A, Series B Extension, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
- Jul 29, 2026
Monthly visitors grew 96% MoM, reaching 2.7K.
Recent news
Latest coverage and updates
- receives_awardSep 15, 2026
VarmX BV received award two industry award on Sep 15th '26.
VarmX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VarmX's valuation, stock price, and market status.
Is VarmX a public or private company?
VarmX is a private company.
What is the current stock price of VarmX?
VarmX is a private company with no public stock price. No recent secondary market data is available.
How much is VarmX worth (valuation)?
Valuation information for VarmX is not publicly available.
Can I buy VarmX stock?
VarmX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VarmX's last funding round?
VarmX's most recent funding round was M&A on September 16, 2024.
Who are the main investors in VarmX?
Key investors in VarmX include European Innovation Council, Ysios Capital, BioGeneration Ventures, Sound Bioventures.
Will VarmX IPO soon?
No public IPO plans have been announced for VarmX.
How can I track VarmX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VarmX's secondary market activity and sign up for updates.